Search Results - "Lewszuk, A."

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy by Backx, M., Lewszuk, A., White, J. R., Cole, J., Sreedharan, A., van Sanden, S., Diels, J., Lawson, A., Neal, K. R., Wiselka, M. J., Ito, T., Irving, W. L.

“…Summary Chronic hepatitis C virus (HCV) infection places a considerable economic burden on health services. Cost‐effectiveness analyses of antiviral treatment…”
Get full text

β Thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis by Kowal-Bielecka, O, Kowal, K, Lewszuk, A, Bodzenta-Lukaszyk, A, Walecki, J, Sierakowski, S

“…Objective: To evaluate concentrations of the platelet activation markers β thromboglobulin (BTG) and platelet factor 4 (PF4) in bronchoalveolar lavage fluid…”
Get full text

Severe respiratory distress caused by central airway obstruction treated with self-expandable metallic stents by Mroz, R M, Kordecki, K, Kozlowski, M D, Baniukiewicz, A, Lewszuk, A, Bondyra, Z, Laudanski, J, Dabrowski, A, Chyczewska, E

“…We investigate retrospectively the efficacy of self-expandable metallic stents (SEMS) for severe respiratory distress (SRD) in patients with central airway…”
Get more information

MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy by Tarasów, E, Panasiuk, A, Siergiejczyk, L, Orzechowska-Bobkiewicz, A, Lewszuk, A, Walecki, J, Prokopowicz, D

“…Hepatic encephalopathy is a serious problem in patients with liver cirrhosis and precise pathophysiological mechanisms responsible for encephalopathy are not…”
Get more information

Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study by O'Connor, Jemma, MSc, Smith, Colette, PhD, Lampe, Fiona C, PhD, Johnson, Margaret A, Prof, Chadwick, David R, MRCP, Nelson, Mark, Prof, Dunn, David, Prof, Winston, Alan, Prof, Post, Frank A, FRCP, Sabin, Caroline, Prof, Phillips, Andrew N, Prof

“…Summary Background The length of time that people with HIV on antiretroviral therapy (ART) with viral load suppression will be able to continue before…”
Get full text

Development and application of a new measure of engagement in out‐patient HIV care by Howarth, AR, Burns, FM, Apea, V, Jose, S, Hill, T, Delpech, VC, Evans, A, Mercer, CH, Michie, S, Morris, S, Sachikonye, M, Sabin, C, Ainsworth, Jonathan, Allan, Sris, Anderson, Jane, Babiker, Abdel, Chadwick, David, Dunn, David, Fisher, Martin, Gazzard, Brian, Gilson, Richard, Gompels, Mark, Hay, Phillip, Johnson, Margaret, Kegg, Stephen, Leen, Clifford, Martin, Fabiola, Nelson, Mark, Orkin, Chloe, Palfreeman, Adrian, Phillips, Andrew, Pillay, Deenan, Post, Frank, Pritchard, Jillian, Schwenk, Achim, Tariq, Anjum, Trevelion, Roy, Walsh, John, Thornton, Alicia, Huntington, Susie, Glabay, Adam, Perry, N., Tilbury, S., Youssef, E., Churchill, D., Everett, R., Asboe, D., Mandalia, S., Korat, H., Taylor, C., Gleisner, Z., Ibrahim, F., Campbell, L., Brima, N., Williams, I., Youle, M., Lampe, F., Smith, C., Tsintas, R., Chaloner, C., Hutchinson, S., Mackie, N., Winston, A., Weber, J., Ramzan, F., Carder, M., Lynch, J., Hand, J., Souza, C., Anderson, J., Munshi, S., Miller, S., Wood, C., Leen, C., Wilson, A., Morris, S., Memon, K., Lewszuk, A., Cope, E., Gibson, J., Main, P., Mitchell, S., Hunter, M., Dhillon, M., Russell‐Sharpe, S., Harte, A., Clay, S., Tariq, A., Spencer, H., Jones, R., Cumming, S., Atkinson, C.

“…Objectives Commonly used measures of engagement in HIV care do not take into account that the frequency of attendance is related to changes in treatment and…”
Get full text

ß Thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis by Kowal-Bielecka, O, Kowal, K, Lewszuk, A, Bodzenta-Lukaszyk, A, Walecki, J, Sierakowski, S

“…Methods: BTG and PF-4 were measured by enzyme immunoassay in BALF from 37 patients with systemic sclerosis. Controls were 10 healthy subjects. BALF was…”
Get full text

Thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis by Kowal-Bielecka, O

“…Objective: To evaluate concentrations of the platelet activation markers β thromboglobulin (BTG) and platelet factor 4 (PF4) in bronchoalveolar lavage fluid…”
Get full text

β thrombolobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis by KOWAL-BIELECKA, O, KOWAL, K, LEWSZUK, A, BODZENTA-LUKASZYK, A, WALECKI, J, SIERAKOWSKI, S

Get full text